Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories

Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories

by Neil Ruzic
     
 

Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories.…  See more details below

Overview

Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories. Lymphoma's incidence is reaching epidemic levels in the United States and Europe. Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients, including those with lymphoma. Ruzic, a former scientific magazine publisher and the originator of a science center, refused to accept this status quo and instead plunged into the world of cutting-edge treatments, exploring the frontiers of cancer science with revolutionary results.

Ruzic went on the offensive: visiting scores of laboratories, gathering information, talking to researchers, and effectively becoming his own patient-care advocate. This book presents his findings. A scathing critique of chemo culture as well as unscientific "alternative" therapies, the book endorses state-of-the-art molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians. Neil Ruzic was expected to die within two years of his initial diagnosis. Five years later he has been declared cancer-free and considers himself cured.

Read More

Editorial Reviews

Library Journal
Science journalist Ruzic, a former NASA consultant, founder of Industrial Research magazine, and creator of the Island for Science (a research center for scientists and engineers), here chronicles his pursuit of a nontoxic cure for his mantle-cell lymphoma. No ordinary patient memoir, this book provides an intriguing glimpse into the world of cutting-edge cancer research from the perspective of a well-heeled, highly educated patient willing to challenge conventional medical wisdom. Instead of undergoing chemotherapy and a bone-marrow transplant, recommended by several oncologists despite poor survival rates, Ruzic visits cancer research laboratories around the country, attempting to enter clinical trials for new biotherapies such as monoclonal antibodies and vaccines. Though eventually successful, he is hampered at every turn by aspects of what he terms the "Chemo Culture"-oncologists who insist on toxic chemotherapy while ignoring newer, safer options and FDA regulations that require chemotherapy before a patient can enroll in clinical trials of new therapies. His oft-repeated rants against oncologists and the FDA can be a bit grating, but his arguments are thought-provoking and deserve a wide audience. Recommended for academic, medical, public, and consumer health collections.-Janet A. Crum, Oregon Health & Science Univ. Lib., Portland Copyright 2003 Reed Business Information.

Product Details

ISBN-13:
9780252028670
Publisher:
University of Illinois Press
Publication date:
08/28/2003
Pages:
448
Product dimensions:
5.90(w) x 9.10(h) x 1.30(d)

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >